Oral Dexmedetomidine in Pediatric MRI
ConditionAnesthesia
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age3-6
SponsorSoroush Merchant
About this trial
The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI.
Eligibility criteria
Qualifiers
Participants 3-6 years old, male and female, all races and ethnicities
Requiring a clinically indicated MRI with general anesthesia
Disqualifiers
Refusal to take oral dexmedetomidine
Known allergy to dexmedetomidine
Inability to take dexmedetomidine at least 90 minutes prior to start of the MRI
Unstable cardiac status including life threatening arrhythmias, abnormal cardiac anatomy, significant cardiac dysfunction
Trial design
Treatments tested in this trial
- Dexmedetomidine
- General Anesthesia (control group)
Treatment groups
18 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Soroush Merchant
Lead sponsor
Children's Mercy Hospital Kansas City
Sponsor institution
Source ClinicalTrials.gov